{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:29:44Z","timestamp":1786480184966,"version":"build-2736575974"},"reference-count":67,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"crossref","award":["RO1 DK127186"],"award-info":[{"award-number":["RO1 DK127186"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"crossref","award":["P30 DK056341"],"award-info":[{"award-number":["P30 DK056341"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"crossref","award":["RO1 DK127186"],"award-info":[{"award-number":["RO1 DK127186"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"crossref","award":["P30 DK056341"],"award-info":[{"award-number":["P30 DK056341"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>An animal protein high-phosphate diet decreased cardiac mitochondrial oxidative phosphorylation in mice with normal kidney function.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>The animal-based protein high-phosphate diet worsened the severity of several CKD-mineral bone disease components in CKD.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>The effects of the diet during normal renal function prime the development and severity of the CKD-mineral bone disease during kidney disease progression.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>CKD-mineral bone disorder (CKD-MBD) is a syndrome that contributes to cardiovascular mortality. We have shown that CKD decreases cardiac mitochondrial function independent of vascular disease and before cardiac hypertrophy. Hyperphosphatemia, a component of the CKD-MBD occurring in later stages of CKD, has been shown to stimulate vascular calcification (VC). In a mouse model of Alport syndrome CKD resistant to VC, we examine the effects of a high-phosphate Western-type diet (HP) on the components of the CKD-MBD, including cardiac respiration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">Col4a5<\/jats:italic>\n                      -deficient mice and wild-type (WT) littermates were fed an animal protein 1.2% high-phosphate diet or a standard vegetable protein 0.6% phosphate diet. At CKD progression equivalent to human CKD stages 4\u20135, we examined cardiac tissue for mitochondrial respiration, kidney histology for fibrosis, blood for BUN and CKD-MBD components, kidney tissue for klotho production, and aorta for VC.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The HP diet produced hyperphosphatemia in the CKD animals compared with WT. The diet increased plasma parathyroid hormone (PTH; 17-fold), fibroblast growth factor 23 (FGF23) intact (14-fold), and reduced kidney klotho mRNA and protein more than 50%. Alport CKD mice fed the HP diet showed a reduction in cardiac mitochondrial complex 2\u2013mediated oxidative phosphorylation, and higher levels of plasma PTH and FGF23 than CKD mice fed the vegetable protein diet. Comparing WT groups, the HP diet increased PTH and intact FGF23, reduced renal klotho, and decreased cardiac mitochondrial oxidative phosphorylation capacity. VC was not induced by the HP diet.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The Western-style high-phosphate diet primed the development of the CKD-MBD in nondiseased animals and worsened the CKD-MBD during CKD progression. Cardiac respiration, renal klotho, FGF23, and PTH are affected by a high-phosphate diet even with normal kidney function, suggesting a need for early intervention in the management of phosphate homeostasis as a component of CKD therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.34067\/kid.0000001065","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T17:00:22Z","timestamp":1767373222000},"page":"955-968","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["A Western Diet High in Phosphate Primes the Development of the CKD-Mineral Bone Disorder in an Alport Syndrome Model"],"prefix":"10.34067","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8704-0133","authenticated-orcid":false,"given":"Matthew J.","family":"Williams","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Nephrology, Washington University in Saint Louis, Saint Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4132-877X","authenticated-orcid":false,"given":"Hiral M.","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nephrology, Washington University in Saint Louis, Saint Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0576-542X","authenticated-orcid":false,"given":"Carley B.","family":"Halling","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nephrology, Washington University in Saint Louis, Saint Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5411-3674","authenticated-orcid":false,"given":"Brian N.","family":"Finck","sequence":"additional","affiliation":[{"name":"Department of Medicine, Nutritional Science and Obesity Medicine, Washington University in Saint Louis, Saint Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4334-9099","authenticated-orcid":false,"given":"Keith A.","family":"Hruska","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nephrology, Washington University in Saint Louis, Saint Louis, Missouri"},{"name":"Department of Cell Biology, Washington University in Saint Louis, Saint Louis, Missouri"},{"name":"Department of Medicine, Nephrology, Washington University in Saint Louis, Saint Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"issue":"12","key":"B2-20260601","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/ki.2011.368","article-title":"The contribution of chronic kidney disease to the global burden of major noncommunicable diseases","volume":"80","author":"Couser","year":"2011","journal-title":"Kidney Int."},{"issue":"2","key":"B3-20260601","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.kisu.2017.07.007","article-title":"Complications of chronic kidney disease: current state, knowledge gaps, and strategy for action","volume":"7","author":"Bello","year":"2017","journal-title":"Kidney Int Suppl (2011)."},{"issue":"9931","key":"B4-20260601","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(14)60384-6","article-title":"Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure","volume":"383","author":"Ortiz","year":"2014","journal-title":"Lancet."},{"issue":"11","key":"B5-20260601","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1093\/ndt\/gfad100","article-title":"Association between CKD-MBD and mortality in older patients with advanced CKD\u2014results from the EQUAL study","volume":"38","author":"Magagnoli","year":"2023","journal-title":"Nephrol Dial Transplant."},{"issue":"5","key":"B6-20260601","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1586\/14779072.2015.1029456","article-title":"Cardiovascular mortality in chronic kidney disease patients: potential mechanisms and possibilities of inhibition by resin-based phosphate binders","volume":"13","author":"Locatelli","year":"2015","journal-title":"Expert Rev Cardiovasc Ther."},{"issue":"4","key":"B7-20260601","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium X phosphate product with mortality risk in chronic hemodialysis patients: a national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis."},{"issue":"6","key":"B8-20260601","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Guti\u00e9rrez","year":"2008","journal-title":"N Engl J Med."},{"issue":"1","key":"B9-20260601","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.atherosclerosis.2014.08.037","article-title":"Fibroblast growth factor 23 (FGF23) and mortality: the Ludwigshafen Risk and Cardiovascular Health Study","volume":"237","author":"Brandenburg","year":"2014","journal-title":"Atherosclerosis."},{"issue":"6","key":"B10-20260601","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1681\/ASN.2014050465","article-title":"Klotho and phosphate are modulators of pathologic uremic cardiac remodeling","volume":"26","author":"Hu","year":"2015","journal-title":"J Am Soc Nephrol."},{"issue":"5","key":"B11-20260601","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.kint.2016.10.034","article-title":"Recombinant \u03b1-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy","volume":"91","author":"Hu","year":"2017","journal-title":"Kidney Int."},{"issue":"1","key":"B12-20260601","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1681\/ASN.2014101030","article-title":"Renal production, uptake, and handling of circulating \u0391klotho","volume":"27","author":"Hu","year":"2016","journal-title":"J Am Soc Nephrol."},{"issue":"5","key":"B13-20260601","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1086\/375035","article-title":"KLOTHO allele status and the risk of early-onset occult coronary artery disease","volume":"72","author":"Arking","year":"2003","journal-title":"Am J Hum Genet."},{"issue":"3","key":"B14-20260601","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1053\/j.ajkd.2003.12.005","article-title":"Vascular calcification in chronic kidney disease","volume":"43","author":"Goodman","year":"2004","journal-title":"Am J Kidney Dis."},{"issue":"9","key":"B15-20260601","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","article-title":"Arterial media calcification in end-stage renal diseases: impact on all-cause and cardiovascular mortality","volume":"18","author":"London","year":"2003","journal-title":"Nephrol Dial Transplant."},{"issue":"2","key":"B16-20260601","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.kint.2022.09.017","article-title":"Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy","volume":"103","author":"Barratt","year":"2023","journal-title":"Kidney Int."},{"issue":"1","key":"B17-20260601","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ki.2013.279","article-title":"High rates of death and hospitalization follow bone fracture among hemodialysis patients","volume":"85","author":"Tentori","year":"2014","journal-title":"Kidney Int."},{"issue":"11","key":"B18-20260601","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int."},{"issue":"1-3","key":"B20-20260601","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000478972","article-title":"Association between extreme values of markers of chronic kidney disease: mineral and bone disorder and 5-year mortality among prevalent hemodialysis patients","volume":"45","author":"Zhu","year":"2018","journal-title":"Blood Purif."},{"issue":"7","key":"B21-20260601","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.2215\/CJN.11931116","article-title":"Association of parameters of mineral bone disorder with mortality in patients on hemodialysis according to level of residual kidney function","volume":"12","author":"Wang","year":"2017","journal-title":"Clin J Am Soc Nephrol."},{"key":"B22-20260601","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2147\/IJNRD.S191156","article-title":"Chronic kidney disease-mineral and bone disorder (CKD-MBD): current perspectives","volume":"12","author":"Waziri","year":"2019","journal-title":"Int J Nephrol Renovasc Dis."},{"issue":"1","key":"B23-20260601","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/ki.2013.271","article-title":"Early chronic kidney disease-mineral bone disorder stimulates vascular calcification","volume":"85","author":"Fang","year":"2014","journal-title":"Kidney Int."},{"issue":"6","key":"B24-20260601","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.bone.2009.08.008","article-title":"Patterns of FGF-23, DMP1 and MEPE expression in patients with chronic kidney disease","volume":"45","author":"Pereira","year":"2009","journal-title":"Bone."},{"issue":"8","key":"B25-20260601","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/jbmr.1630","article-title":"Repression of osteocyte Wnt\/\u03b2-catenin signaling is an early event in the progression of renal osteodystrophy","volume":"27","author":"Sabbagh","year":"2012","journal-title":"J Bone Miner Res."},{"issue":"6","key":"B26-20260601","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.kint.2016.12.029","article-title":"The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease","volume":"91","author":"Graciolli","year":"2017","journal-title":"Kidney Int."},{"issue":"11","key":"B27-20260601","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/jbmr.485","article-title":"The pathophysiology of early-stage chronic kidney disease\u2013mineral bone disorder (CKD-MBD) and response to phosphate binders in the rat","volume":"26","author":"Moe","year":"2011","journal-title":"J Bone Miner Res."},{"issue":"4","key":"B28-20260601","first-page":"303","article-title":"Pathophysiology of the chronic kidney disease - mineral bone disorder","volume":"24","author":"Hruska","year":"2015","journal-title":"Curr Opin Nephrol Hypertens."},{"issue":"5","key":"B29-20260601","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1159\/000362251","article-title":"Left ventricular mass progression despite stable blood pressure and kidney function in stage 3 chronic kidney disease","volume":"39","author":"Seifert","year":"2014","journal-title":"Am J Nephrol."},{"key":"B30-20260601","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bone.2017.01.023","article-title":"The chronic kidney disease \u2014 mineral bone disorder (CKD-MBD): advances in pathophysiology","volume":"100","author":"Hruska","year":"2017","journal-title":"Bone."},{"issue":"2","key":"B31-20260601","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ki.2008.130","article-title":"Hyperphosphatemia of chronic kidney disease","volume":"74","author":"Hruska","year":"2008","journal-title":"Kidney Int."},{"issue":"11","key":"B32-20260601","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jama.2011.308","article-title":"Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis","volume":"305","author":"Palmer","year":"2011","journal-title":"JAMA."},{"issue":"3","key":"B33-20260601","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1161\/ATVBAHA.123.319198","article-title":"Phosphate in cardiovascular disease: from new insights into molecular mechanisms to clinical implications","volume":"44","author":"Turner","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"4","key":"B34-20260601","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/ki.1982.184","article-title":"Effects of dietary protein and phosphorus restriction on the progression of early renal failure","volume":"22","author":"Maschio","year":"1982","journal-title":"Kidney Int."},{"issue":"11","key":"B35-20260601","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest."},{"issue":"5","key":"B36-20260601","doi-asserted-by":"crossref","first-page":"F751","DOI":"10.1152\/ajprenal.00416.2023","article-title":"In chronic kidney disease altered cardiac metabolism precedes cardiac hypertrophy","volume":"326","author":"Williams","year":"2024","journal-title":"Am J Physiol Renal Physiol."},{"issue":"2","key":"B37-20260601","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.kint.2022.03.028","article-title":"Soluble alpha-klotho and heparin modulate the pathologic cardiac actions of fibroblast growth factor 23 in chronic kidney disease","volume":"102","author":"Yanucil","year":"2022","journal-title":"Kidney Int."},{"issue":"5","key":"B38-20260601","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.kint.2025.01.024","article-title":"Fibroblast growth factor 23 and fibroblast growth factor receptor 4 promote cardiac metabolic remodeling in chronic kidney disease","volume":"107","author":"Fuchs","year":"2025","journal-title":"Kidney Int."},{"issue":"6","key":"B39-20260601","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1097\/01.ASN.0000130562.90255.8F","article-title":"Mouse model of X-linked Alport syndrome","volume":"15","author":"Rheault","year":"2004","journal-title":"J Am Soc Nephrol."},{"issue":"7","key":"B40-20260601","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods."},{"issue":"5","key":"B41-20260601","doi-asserted-by":"crossref","first-page":"H1202","DOI":"10.1152\/ajpheart.00013.2019","article-title":"A maternal high-fat, high-sucrose diet induces transgenerational cardiac mitochondrial dysfunction independently of maternal mitochondrial inheritance","volume":"316","author":"Ferey","year":"2019","journal-title":"Am J Physiol Heart Circ Physiol."},{"issue":"9","key":"B42-20260601","doi-asserted-by":"crossref","first-page":"E715","DOI":"10.1152\/ajpendo.00475.2015","article-title":"Measurement of \u03b2-oxidation capacity of biological samples by respirometry: a review of principles and substrates","volume":"310","author":"Ojuka","year":"2016","journal-title":"Am J Physiol Endocrinol Metab."},{"issue":"5","key":"B43-20260601","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2337\/db20-0688","article-title":"Deficits in the skeletal muscle transcriptome and mitochondrial coupling in progressive diabetes-induced CKD relate to functional decline","volume":"70","author":"Bittel","year":"2021","journal-title":"Diabetes."},{"issue":"4","key":"B44-20260601","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1053\/j.ajkd.2016.08.002","article-title":"AJKD Atlas of renal pathology: Alport syndrome","volume":"68","author":"Fogo","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"B45-20260601","doi-asserted-by":"crossref","first-page":"e3772","DOI":"10.1371\/journal.pone.0003772","article-title":"Age-related reference intervals of the main biochemical and hematological parameters in C57BL\/J, 129 SV\/EV and C3H\/HeJ mouse strain","volume":"3","author":"Mazzaccara","year":"2008","journal-title":"PLoS One."},{"issue":"1","key":"B46-20260601","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000452880","article-title":"Klotho\/FGF23 axis in chronic kidney disease and cardiovascular disease","volume":"3","author":"Lu","year":"2017","journal-title":"Kidney Dis (Basel)."},{"issue":"121","key":"B47-20260601","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1038\/ki.2011.26","article-title":"Phosphate and klotho","volume":"7","author":"Kuro-o","year":"2011","journal-title":"Kidney Int."},{"issue":"10","key":"B48-20260601","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1074\/jbc.C500457200","article-title":"Regulation of fibroblast growth factor-23 signaling by Klotho","volume":"281","author":"Kurosu","year":"2006","journal-title":"J Biol Chem."},{"key":"B49-20260601","doi-asserted-by":"crossref","first-page":"974361","DOI":"10.3389\/fphar.2022.974361","article-title":"The interaction between cellular senescence and chronic kidney disease as a therapeutic opportunity","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Pharmacol."},{"issue":"2","key":"B50-20260601","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1053\/j.ajkd.2012.11.051","article-title":"Chronic kidney disease: a clinical model of premature aging","volume":"62","author":"Stenvinkel","year":"2013","journal-title":"Am J Kidney Dis."},{"key":"B51-20260601","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3389\/fendo.2020.00560","article-title":"Klotho, aging, and the failing kidney","volume":"11","author":"Buchanan","year":"2020","journal-title":"Front Endocrinol."},{"issue":"6655","key":"B52-20260601","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/36285","article-title":"Mutation of the mouse klotho gene leads to a syndrome resembling ageing","volume":"390","author":"Kuro-o","year":"1997","journal-title":"Nature."},{"issue":"12","key":"B54-20260601","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/ki.2010.328","article-title":"Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective","volume":"78","author":"Hu","year":"2010","journal-title":"Kidney Int."},{"issue":"10","key":"B55-20260601","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1681\/ASN.2011020175","article-title":"Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition","volume":"22","author":"Zoccali","year":"2011","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"B56-20260601","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2215\/CJN.05040610","article-title":"Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease","volume":"6","author":"Moe","year":"2011","journal-title":"Clin J Am Soc Nephrol."},{"issue":"7","key":"B57-20260601","doi-asserted-by":"crossref","first-page":"950","DOI":"10.2215\/CJN.0000000730","article-title":"Effects of lowering dietary phosphorus additive intake on mineral metabolism in adults with and without CKD","volume":"20","author":"Khan","year":"2025","journal-title":"Clin J Am Soc Nephrol."},{"issue":"21","key":"B58-20260601","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1136\/hrt.2008.162594","article-title":"Is lowering phosphate exposure the key to preventing arterial stiffening with age?","volume":"95","author":"Ferro","year":"2009","journal-title":"Heart."},{"issue":"1","key":"B59-20260601","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.jrn.2023.08.010","article-title":"In the \u201cplant-based\u201d era, patients with chronic kidney disease should focus on eating healthy","volume":"34","author":"Freeman","year":"2024","journal-title":"J Ren Nutr."},{"key":"B60-20260601","article-title":"The role of precision nutrition in kidney disease","author":"Narasaki","journal-title":"Clin J Am Soc Nephrol."},{"issue":"8","key":"B61-20260601","doi-asserted-by":"crossref","first-page":"e99123","DOI":"10.1172\/jci.insight.99123","article-title":"Canagliflozin triggers the FGF23\/1,25-dihydroxyvitamin D\/PTH axis in healthy volunteers in a randomized crossover study","volume":"3","author":"Blau","year":"2018","journal-title":"JCI Insight."},{"issue":"4","key":"B62-20260601","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/MNH.0000000000000505","article-title":"Effects of sodium glucose cotransporter 2 inhibitors on mineral metabolism in type 2 diabetes mellitus","volume":"28","author":"Vinke","year":"2019","journal-title":"Curr Opin Nephrol Hypertens."},{"issue":"1","key":"B63-20260601","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S2213-8587(14)70227-X","article-title":"Possible adverse effects of SGLT2 inhibitors on bone","volume":"3","author":"Taylor","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"3","key":"B64-20260601","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/gerona\/glab308","article-title":"Low serum klotho associated with all-cause mortality among a nationally representative sample of American adults","volume":"77","author":"Kresovich","year":"2022","journal-title":"J Gerontol A Biol Sci Med Sci."},{"issue":"10","key":"B65-20260601","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1681\/ASN.2010121224","article-title":"FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis","volume":"22","author":"Kendrick","year":"2011","journal-title":"J Am Soc Nephrol."},{"issue":"4","key":"B66-20260601","doi-asserted-by":"crossref","first-page":"F691","DOI":"10.1152\/ajprenal.90623.2008","article-title":"The Na+-Pi cotransporter PiT-2 (SLC20A2) is expressed in the apical membrane of rat renal proximal tubules and regulated by dietary Pi","volume":"296","author":"Villa-Bellosta","year":"2009","journal-title":"Am J Physiol Renal Physiol."},{"issue":"3","key":"B67-20260601","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/j.ajkd.2024.02.008","article-title":"Klotho and clinical outcomes in CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study","volume":"84","author":"Edmonston","year":"2024","journal-title":"Am J Kidney Dis."},{"issue":"2","key":"B68-20260601","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/ckj\/sfz085","article-title":"Performance of soluble Klotho assays in clinical samples of kidney disease","volume":"13","author":"Neyra","year":"2020","journal-title":"Clin Kidney J."},{"issue":"1","key":"B69-20260601","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.kint.2017.06.016","article-title":"The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease","volume":"93","author":"Williams","year":"2018","journal-title":"Kidney Int."},{"issue":"8","key":"B70-20260601","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/jbmr.1923","article-title":"Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women","volume":"28","author":"Wolf","year":"2013","journal-title":"J Bone Miner Res."}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000001065","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T19:56:09Z","timestamp":1786478169000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000001065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0000001065","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.01.17.633378","asserted-by":"object"}]},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,2]]},"assertion":[{"value":"2025-07-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}